Carl Icahn is a billionaire financier, ranking #18 on the 2007 Forbes 400 list with an estimated net worth of $14.5 billion.
Icahn built a name for himself in the 1980s as a corporate raider. After keeping quite for years, Icahn made a major comeback as a 'activist investor'. An activist investor agitates companies for changes, including buyouts, share buybacks, and dividend increases.
In 2007, Icahn's activism successfully pushed biotech company MedImmune into a sales agreement with AstraZeneca (NYSE: AZN). Icahn is also involved with biotech company Imclone Systems (Nasdaq: IMCL), where he is Chairman of the Board.
Icahn is also involved with developments at Biogen Idec (Nasdaq: BIIB) and WCI Communities (NYSE: WCI), which both unsuccessfully explored sales. WCI rejected a $22 per share takeover offer from Icahn in early 2007, only to see its stock plummet on the housing slowdown.
In 2008, Icahn targeted Yahoo! (Nasdaq: YHOO) after the Internet company failed to work out an acceptable merger agreement with Microsoft (Nasdaq: MSFT) Microsoft walked away from its bid for Yahoo! after months of bickering.
Carl Icahn's Portfolio
|Company||Ticker||# of Shares||Change||Price||Value|
|ICAHN ENT DEP UTS||IEP||123,551,872||+5,832,687||$50.71||$6,265,315,430||History »||Related Stories »|
|American International Group, Inc.||AIG||45,644,982||+1,222,796||$59.43||$2,712,681,281||History »||Related Stories »|
|CHENIERE ENERGY, Inc.||LNG||32,680,490||$44.06||$1,439,902,390||History »||Related Stories »|
|PayPal||PYPL||33,897,153||-3,931,266||$37.29||$1,264,024,836||History »||Related Stories »|
|Federal-Mogul Corporation||FDML||138,590,141||$9.04||$1,252,854,875||History »||Related Stories »|
|Freeport-McMoran Cp & Gld||FCX||104,000,000||$10.98||$1,141,920,000||History »||Related Stories »|
|HERBALIFE LTD.||HLF||17,000,000||$63.30||$1,076,100,000||History »||Related Stories »|
|CVR ENERGY, Inc.||CVI||71,198,718||$14.15||$1,007,461,860||History »||Related Stories »|
|Xerox Corp.||XRX||99,030,026||+6,652,983||$9.69||$959,600,952||History »||Related Stories »|
|Allergan Inc||AGN||3,400,000||+3,400,000||$236.65||$804,610,000||History »||Related Stories »|
|Hertz Global||HTZ||12,938,596||-50,770,487||$50.61||$654,822,344||History »||Related Stories »|
|Chesapeake Energy||CHK||73,050,000||$6.44||$470,442,000||History »||Related Stories »|
|Nuance Communications, Inc.||NUAN||21,653,884||-8,414,949||$14.42||$312,249,008||History »||Related Stories »|
|NAVISTAR INTERNATIONAL||NAV||16,272,524||$14.63||$238,067,027||History »||Related Stories »|
|Transocean||RIG||21,477,900||$10.11||$217,141,569||History »||Related Stories »|
|FreightCar America, Inc.||RAIL||11,871,268||$14.56||$172,845,663||History »||Related Stories »|
|National Medical Financial Services Corporation||MFS||10,582,660||$16.04||$169,745,867||History »||Related Stories »|
|China Health Resource, Inc. Class A||HRI||4,312,860||+4,312,860||$32.69||$140,987,394||History »||Related Stories »|
|MANITOWOC COMPANY, Inc.||MTW||10,582,660||$4.94||$52,278,341||History »||Related Stories »|
|CVR REFINING LP||CVRR||6,000,000||$6.76||$40,560,000||History »||Related Stories »|
|VOLTARI||VLTC||4,739,620||$3.02||$14,313,653||History »||Related Stories »|
|Enzon Pharmaceuticals, Inc.||ENZN||Liquidated||History »||Related Stories »|
|Southern Connecticut Bancorp, Inc.||SSE||Liquidated||History »||Related Stories »|